Corcept Therapeutics Inc banner

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 37.6 USD -2.41% Market Closed
Market Cap: $4B

Wall Street
Price Targets

CORT Price Targets Summary
Corcept Therapeutics Inc

Wall Street analysts forecast CORT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CORT is 68.14 USD with a low forecast of 44.44 USD and a high forecast of 105 USD.

Lowest
Price Target
44.44 USD
18% Upside
Average
Price Target
68.14 USD
81% Upside
Highest
Price Target
105 USD
179% Upside
Corcept Therapeutics Inc Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate of Corcept Therapeutics Inc's revenue for the next 3 years is 26%.

Operating Income
Forecast

N/A
Past Growth
131% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
131% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate of Corcept Therapeutics Inc's operating income for the next 3 years is 131%.

Net Income
Forecast

N/A
Past Growth
67% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
67% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate of Corcept Therapeutics Inc's net income for the next 3 years is 67%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CORT's stock price target?
Price Target
68.14 USD

According to Wall Street analysts, the average 1-year price target for CORT is 68.14 USD with a low forecast of 44.44 USD and a high forecast of 105 USD.

What is Corcept Therapeutics Inc's Revenue forecast?
Projected CAGR
26%

The compound annual growth rate of Corcept Therapeutics Inc's revenue for the next 3 years is 26%.

What is Corcept Therapeutics Inc's Operating Income forecast?
Projected CAGR
131%

The compound annual growth rate of Corcept Therapeutics Inc's operating income for the next 3 years is 131%.

What is Corcept Therapeutics Inc's Net Income forecast?
Projected CAGR
67%

The compound annual growth rate of Corcept Therapeutics Inc's net income for the next 3 years is 67%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett